{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T06:03:35Z","timestamp":1759385015073},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,3]],"date-time":"2015-10-03T00:00:00Z","timestamp":1443830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12020-015-0757-9","type":"journal-article","created":{"date-parts":[[2015,10,3]],"date-time":"2015-10-03T06:36:59Z","timestamp":1443854219000},"page":"93-102","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Factors associated with 1,25-dihydroxyvitamin D3 concentrations in liver transplant recipients: a prospective observational longitudinal study"],"prefix":"10.1007","volume":"52","author":[{"given":"Agnieszka","family":"Prytu\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan Vande","family":"Walle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Fiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Dehoorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Raes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,3]]},"reference":[{"issue":"8","key":"757_CR1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/jbmr.2214","volume":"29","author":"CG Krol","year":"2014","unstructured":"C.G. Krol, O.M. Dekkers, H.M. Kroon, T.J. Rabelink, B. van Hoek, N.A. Hamdy, Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatment. J. Bone Miner. Res. 29(8), 1763\u20131769 (2014). doi: 10.1002\/jbmr.2214","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"757_CR2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980070109","volume":"11","author":"S Giannini","year":"2000","unstructured":"S. Giannini, M. Nobile, M. Ciuffreda, R.M. Iemmolo, L. Dalle Carbonare, N. Minicuci, F. Casagrande, C. Destro, G.E. Gerunda, L. Sartori, G. Crepaldi, Long-term persistence of low bone density in orthotopic liver transplantation. Osteoporos. Int. 11(5), 417\u2013424 (2000). doi: 10.1007\/s001980070109","journal-title":"Osteoporos. Int."},{"issue":"6","key":"757_CR3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s001980170094","volume":"12","author":"A Monegal","year":"2001","unstructured":"A. Monegal, M. Navasa, N. Guanabens, P. Peris, F. Pons, M.J. Martinez de Osaba, J. Ordi, A. Rimola, J. Rodes, J. Munoz-Gomez, Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos. Int. 12(6), 484\u2013492 (2001). doi: 10.1007\/s001980170094","journal-title":"Osteoporos. Int."},{"issue":"2","key":"757_CR4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1478-3231.2011.02638.x","volume":"32","author":"PP Reese","year":"2012","unstructured":"P.P. Reese, R.D. Bloom, H.I. Feldman, A. Huverserian, A. Thomasson, J. Shults, T. Hamano, S. Goral, A. Shaked, K. Olthoff, M.R. Rickels, M. Bleicher, M.B. Leonard, Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int. 32(2), 287\u2013296 (2012). doi: 10.1111\/j.1478-3231.2011.02638.x","journal-title":"Liver Int."},{"issue":"3","key":"757_CR5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1399-0012.2010.01305.x","volume":"25","author":"KA Simo","year":"2011","unstructured":"K.A. Simo, S. Sereika, N. Bitner, K.N. Newton, D.A. Gerber, Medical epidemiology of patients surviving ten years after liver transplantation. Clin. Transplant. 25(3), 360\u2013367 (2011). doi: 10.1111\/j.1399-0012.2010.01305.x","journal-title":"Clin. Transplant."},{"issue":"2","key":"757_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/cc11207","volume":"16","author":"C Francoz","year":"2012","unstructured":"C. Francoz, F. Durand, A new look at renal dysfunction in the cirrhotic patient. Crit. Care 16(2), 118 (2012). doi: 10.1186\/cc11207","journal-title":"Crit. Care"},{"issue":"12","key":"757_CR7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tibs.2004.10.005","volume":"29","author":"DE Prosser","year":"2004","unstructured":"D.E. Prosser, G. Jones, Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 29(12), 664\u2013673 (2004). doi: 10.1016\/j.tibs.2004.10.005","journal-title":"Trends Biochem. Sci."},{"key":"757_CR8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsbmb.2012.09.012","volume":"136","author":"Z Wang","year":"2013","unstructured":"Z. Wang, E.G. Schuetz, Y. Xu, K.E. Thummel, Interplay between vitamin D and the drug metabolizing enzyme CYP3A4. J. Steroid Biochem. Mol. Biol. 136, 54\u201358 (2013). doi: 10.1016\/j.jsbmb.2012.09.012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"757_CR9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/mol.105.017392","volume":"69","author":"Y Xu","year":"2006","unstructured":"Y. Xu, T. Hashizume, M.C. Shuhart, C.L. Davis, W.L. Nelson, T. Sakaki, T.F. Kalhorn, P.B. Watkins, E.G. Schuetz, K.E. Thummel, Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol. Pharmacol. 69(1), 56\u201365 (2006). doi: 10.1124\/mol.105.017392","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"757_CR10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003495-199754060-00009","volume":"54","author":"CM Spencer","year":"1997","unstructured":"C.M. Spencer, K.L. Goa, J.C. Gillis, Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54(6), 925\u2013975 (1997)","journal-title":"Drugs"},{"issue":"11","key":"757_CR11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","volume":"41","author":"U Christians","year":"2002","unstructured":"U. Christians, W. Jacobsen, L.Z. Benet, A. Lampen, Mechanisms of clinically relevant drug interactions associated with tacrolimus. Clin. Pharmacokinet. 41(11), 813\u2013851 (2002). doi: 10.2165\/00003088-200241110-00003","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"757_CR12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1357-2725(97)00027-7","volume":"29","author":"K Izuishi","year":"1997","unstructured":"K. Izuishi, H. Wakabayashi, T. Ohnishi, H. Maeta, T. Maeba, Y. Ichikawa, Effects of an immunosuppressive agent, tacrolimus (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems in rat liver microsomes. Int. J. Biochem. Cell Biol. 29(6), 921\u2013928 (1997)","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"757_CR13","doi-asserted-by":"crossref","unstructured":"E. Stein, P. Ebeling, E. Shane, Post-transplantation osteoporosis. Endocrinol. Metab. Clin. N. Am. 36(4), 937\u2013963; viii (2007). doi: 10.1016\/j.ecl.2007.07.008","DOI":"10.1016\/j.ecl.2007.07.008"},{"issue":"3","key":"757_CR14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1210\/endo-128-3-1369","volume":"128","author":"B Stein","year":"1991","unstructured":"B. Stein, B.P. Halloran, T. Reinhardt, G.W. Engstrom, C.W. Bales, M.K. Drezner, K.L. Currie, M. Takizawa, J.S. Adams, S. Epstein, Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse. Endocrinology 128(3), 1369\u20131373 (1991). doi: 10.1210\/endo-128-3-1369","journal-title":"Endocrinology"},{"issue":"1","key":"757_CR15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000328874","volume":"34","author":"CT Lee","year":"2011","unstructured":"C.T. Lee, H.Y. Ng, Y.H. Lien, L.W. Lai, M.S. Wu, C.R. Lin, H.C. Chen, Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism. Am. J. Nephrol. 34(1), 87\u201394 (2011). doi: 10.1159\/000328874","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"757_CR16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1600-6143.2007.01753.x","volume":"7","author":"P Evenepoel","year":"2007","unstructured":"P. Evenepoel, M. Naesens, K. Claes, D. Kuypers, Y. Vanrenterghem, Tertiary \u2018hyperphosphatoninism\u2019 accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am. J. Transplant. 7(5), 1193\u20131200 (2007). doi: 10.1111\/j.1600-6143.2007.01753.x","journal-title":"Am. J. Transplant."},{"issue":"1","key":"757_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1255\/ejms.1024","volume":"16","author":"B Casetta","year":"2010","unstructured":"B. Casetta, I. Jans, J. Billen, D. Vanderschueren, R. Bouillon, Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur. J. Mass Spectrom. 16(1), 81\u201389 (2010). doi: 10.1255\/ejms.1024","journal-title":"Eur. J. Mass Spectrom."},{"issue":"1","key":"757_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, S.T. Mayne, C.J. Rosen, S.A. Shapses, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocr. Metab. 96(1), 53\u201358 (2011). doi: 10.1210\/Jc.2010-2704","journal-title":"J. Clin. Endocr. Metab."},{"issue":"5893","key":"757_CR19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"R.B. Payne, A.J. Little, R.B. Williams, J.R. Milner, Interpretation of serum calcium in patients with abnormal serum proteins. Br. Med. J. 4(5893), 643\u2013646 (1973)","journal-title":"Br. Med. J."},{"issue":"9","key":"757_CR20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh, E.P.I. Ckd, A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604\u2013612 (2009)","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"757_CR21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"P.S. Kamath, W.R. Kim, Advanced Liver Disease Study Group, The model for end-stage liver disease (MELD). Hepatology 45(3), 797\u2013805 (2007). doi: 10.1002\/hep.21563","journal-title":"Hepatology"},{"issue":"3","key":"757_CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357(3), 266\u2013281 (2007). doi: 10.1056\/NEJMra070553","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"757_CR23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1043-2760(00)00317-9","volume":"11","author":"P White","year":"2000","unstructured":"P. White, N. Cooke, The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol. Metab. 11(8), 320\u2013327 (2000)","journal-title":"Trends Endocrinol. Metab."},{"issue":"1\u20132","key":"757_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2006.03.011","volume":"372","author":"M Speeckaert","year":"2006","unstructured":"M. Speeckaert, G. Huang, J.R. Delanghe, Y.E. Taes, Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta 372(1\u20132), 33\u201342 (2006). doi: 10.1016\/j.cca.2006.03.011","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"757_CR25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1210\/edrv-10-3-294","volume":"10","author":"NE Cooke","year":"1989","unstructured":"N.E. Cooke, J.G. Haddad, Vitamin D binding protein (Gc-globulin). Endocr. Rev. 10(3), 294\u2013307 (1989). doi: 10.1210\/edrv-10-3-294","journal-title":"Endocr. Rev."},{"key":"757_CR26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/lt.22128","volume":"10","author":"C Francoz","year":"2010","unstructured":"C. Francoz, D. Prie, W. Abdelrazek, R. Moreau, A. Mandot, J. Belghiti, D. Valla, F. Durand, Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl. 10, 1169\u20131177 (2010). doi: 10.1002\/lt.22128","journal-title":"Liver Transpl."},{"issue":"6","key":"757_CR27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1651-2227.1997.tb08940.x","volume":"86","author":"A Moulas","year":"1997","unstructured":"A. Moulas, A. Challa, N. Chaliasos, P.D. Lapatsanis, Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in beta-thalassaemia. Acta Paediatr. 86(6), 594\u2013599 (1997)","journal-title":"Acta Paediatr."},{"issue":"4","key":"757_CR28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MNH.0b013e3283477a7b","volume":"20","author":"M Petkovich","year":"2011","unstructured":"M. Petkovich, G. Jones, CYP24A1 and kidney disease. Curr. Opin. Nephrol. Hypertens. 20(4), 337\u2013344 (2011). doi: 10.1097\/MNH.0b013e3283477a7b","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"6","key":"757_CR29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1373\/clinchem.2015.240051","volume":"61","author":"AH Berg","year":"2015","unstructured":"A.H. Berg, C.E. Powe, M.K. Evans, J. Wenger, G. Ortiz, A.B. Zonderman, P. Suntharalingam, K. Lucchesi, N.R. Powe, S.A. Karumanchi, R.I. Thadhani, 24,25-Dihydroxyvitamin D3 and vitamin D status of community-dwelling black and white Americans. Clin. Chem. 61(6), 877\u2013884 (2015). doi: 10.1373\/clinchem.2015.240051","journal-title":"Clin. Chem."},{"issue":"3","key":"757_CR30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/jpet.109.160804","volume":"332","author":"V Lamba","year":"2010","unstructured":"V. Lamba, J.C. Panetta, S. Strom, E.G. Schuetz, Genetic predictors of interindividual variability in hepatic CYP3A4 expression. J. Pharm. Exp. Ther. 332(3), 1088\u20131099 (2010). doi: 10.1124\/jpet.109.160804","journal-title":"J. Pharm. Exp. Ther."},{"issue":"6","key":"757_CR31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1124\/mol.60.6.1399","volume":"60","author":"KE Thummel","year":"2001","unstructured":"K.E. Thummel, C. Brimer, K. Yasuda, J. Thottassery, T. Senn, Y. Lin, H. Ishizuka, E. Kharasch, J. Schuetz, E. Schuetz, Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol. Pharmacol. 60(6), 1399\u20131406 (2001)","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"757_CR32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.ASN.0000113318.56023.B6","volume":"15","author":"T Nijenhuis","year":"2004","unstructured":"T. Nijenhuis, J.G. Hoenderop, R.J. Bindels, Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J. Am. Soc. Nephrol. 15(3), 549\u2013557 (2004)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"757_CR33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/jc.2012-2772","volume":"98","author":"D Vanderschueren","year":"2013","unstructured":"D. Vanderschueren, S.R. Pye, T.W. Oneill, D.M. Lee, I. Jans, J. Billen, E. Gielen, M. Laurent, F. Claessens, J.E. Adams, K.A. Ward, G. Bartfai, F.F. Casanueva, J.D. Finn, G. Forti, A. Giwercman, T.S. Han, I.T. Huhtaniemi, K. Kula, M.E. Lean, N. Pendleton, M. Punab, F.C. Wu, S. Boonen, Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J. Clin. Endocrinol. Metab. 98(3), 995\u20131005 (2013). doi: 10.1210\/jc.2012-2772","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"757_CR34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"A. Levin, G.L. Bakris, M. Molitch, M. Smulders, J. Tian, L.A. Williams, D.L. Andress, Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 71(1), 31\u201338 (2007). doi: 10.1038\/sj.ki.5002009","journal-title":"Kidney Int."},{"issue":"6","key":"757_CR35","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1681\/ASN.2007090993","volume":"19","author":"R Shroff","year":"2008","unstructured":"R. Shroff, M. Egerton, M. Bridel, V. Shah, A.E. Donald, T.J. Cole, M.P. Hiorns, J.E. Deanfield, L. Rees, A bimodal association of vitamin D levels and vascular disease in children on dialysis. J. Am. Soc. Nephrol. 19(6), 1239\u20131246 (2008). doi: 10.1681\/ASN.2007090993","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"757_CR36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/ctr.12351","volume":"28","author":"RL Corey","year":"2014","unstructured":"R.L. Corey, M.D. Whitaker, M.D. Crowell, M.T. Keddis, B. Aqel, V. Balan, T. Byrne, E. Carey, D.D. Douglas, M.E. Harrison, H.E. Vargas, J. Rakela, Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation. Clin. Transplant. 28(5), 579\u2013584 (2014). doi: 10.1111\/ctr.12351","journal-title":"Clin. Transplant."},{"issue":"8","key":"757_CR37","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.2008111157","volume":"20","author":"IH Boer de","year":"2009","unstructured":"I.H. de Boer, B. Kestenbaum, A.B. Shoben, E.D. Michos, M.J. Sarnak, D.S. Siscovick, 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J. Am. Soc. Nephrol. 20(8), 1805\u20131812 (2009). doi: 10.1681\/ASN.2008111157","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"757_CR38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1067\/mai.2000.110101","volume":"106","author":"O Jirapongsananuruk","year":"2000","unstructured":"O. Jirapongsananuruk, I. Melamed, D.Y. Leung, Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J. Allergy Clin. Immunol. 106(5), 981\u2013985 (2000). doi: 10.1067\/mai.2000.110101","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"757_CR39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1523-1755.2002.00101.x","volume":"61","author":"CA Redaelli","year":"2002","unstructured":"C.A. Redaelli, M. Wagner, D. Gunter-Duwe, Y.H. Tian, P.F. Stahel, L. Mazzucchelli, R.A. Schmid, M.K. Schilling, 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Kidney Int. 61(1), 288\u2013296 (2002). doi: 10.1046\/j.1523-1755.2002.00101.x","journal-title":"Kidney Int."},{"key":"757_CR40","author":"L Cianferotti","year":"2015","unstructured":"L. Cianferotti, C. Cricelli, J.A. Kanis, R. Nuti, J.Y. Reginster, J.D. Ringe, R. Rizzoli, M.L. Brandi, The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Endocrine (2015). doi: 10.1007\/s12020-015-0606-x","journal-title":"Endocrine"},{"issue":"9","key":"757_CR41","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-200112000-00005","volume":"11","author":"E Hustert","year":"2001","unstructured":"E. Hustert, M. Haberl, O. Burk, R. Wolbold, Y.Q. He, K. Klein, A.C. Nuessler, P. Neuhaus, J. Klattig, R. Eiselt, I. Koch, A. Zibat, J. Brockmoller, J.R. Halpert, U.M. Zanger, L. Wojnowski, The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 11(9), 773\u2013779 (2001)","journal-title":"Pharmacogenetics"},{"issue":"4","key":"757_CR42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","volume":"27","author":"P Kuehl","year":"2001","unstructured":"P. Kuehl, J. Zhang, Y. Lin, J. Lamba, M. Assem, J. Schuetz, P.B. Watkins, A. Daly, S.A. Wrighton, S.D. Hall, P. Maurel, M. Relling, C. Brimer, K. Yasuda, R. Venkataramanan, S. Strom, K. Thummel, M.S. Boguski, E. Schuetz, Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 27(4), 383\u2013391 (2001). doi: 10.1038\/86882","journal-title":"Nat. Genet."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0757-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0757-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T05:00:39Z","timestamp":1599627639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-015-0757-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s12020-015-0757-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,3]]}}}